VELCADE® (bortezomib)

VELCADE Reimbursement Assistance Program

Welcome to the VELCADE Reimbursement Assistance Program (VRAP), where it’s our goal to help you get the treatment your doctor has prescribed, no matter your insurance or financial situation.

Multiple myeloma and relapsed mantle cell lymphoma often require expensive treatment regimens, so it is important to understand how your insurance coverage works. Understanding your insurance coverage will help you understand the out-of-pocket expenses for which you may be responsible.

VRAP is available to patients, physicians, and caregivers to provide assistance regarding reimbursement issues related to the use of VELCADE® (bortezomib) for Injection. The program is easily accessed by calling 1-866-VELCADE, option 2. Dedicated Case Managers are available from 8:00 am to 8:00 pm Eastern Standard Time (EST).

How VELCADE® (bortezomib) Works

page sponsored by VELCADE®

VELCADE is an important option for treating patients with multiple myeloma and patients with relapsed mantle cell lymphoma (MCL) because it gives you another way to fight your disease. VELCADE is a type of medicine called a proteasome (pro-tee-uh-zohm) inhibitor. It is the only proteasome inhibitor the FDA has approved.

What Are Proteasomes?

Proteasomes are protein complexes inside all human cells, both healthy and cancerous. They work by breaking down unneeded or damaged proteins in your cells. This normal process maintains a balance within the cell, allowing cells to live and grow.

What Is a Proteasome Inhibitor?

VELCADE is a proteasome inhibitor that temporarily blocks, or inhibits, proteasomes from breaking down proteins. This causes a buildup of proteins in the cell. When there are too many proteins in the cells, the cells stop growing and die.

Take a Closer Look at Proteasome Inhibition

Proteasomes are inside all human cells and break down proteins.

Proteasome inhibitors block the proteasome from working, causing a buildup of proteins in the cell.

This buildup of proteins can cause cells—including cancer cells—to die, as well as slow tumor growth.

Please click here To request a Patient Resource Kit for VELCADE® (bortezomib). This complimentary kit includes information about VELCADE for multiple myeloma or relapsed MCL along with tools to help you manage your disease.

VELCADE may be able to help treat your multiple myeloma or relapsed mantle cell lymphoma.

VELCADE is the first treatment approved by the FDA from a class of medicines called proteasome inhibitors. VELCADE is an effective treatment for patients with multiple myeloma and relapsed mantle cell lymphoma and is given intravenously as a 3- to 5-second injection. To date, more than 160,000 patients have been treated with VELCADE.* Learn how proteasome inhibitors work.

VELCADE can be used to treat many patients, including the elderly and those with kidney disease.

VELCADE should not be used in patients who are pregnant, planning to become pregnant or breastfeeding, as well as those who are allergic or hyper-sensitive to bortezomib, boron or mannitol, the ingredients VELCADE is made of.

You and your doctor will discuss your treatment options to decide if VELCADE is an option for you. Learn more about considering VELCADE.

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...